Skip to main content
. 2019 May 29;8(11):e011358. doi: 10.1161/JAHA.118.011358

Figure 2.

Figure 2

Propensity‐weighted cumulative risk of dementia by age and treatment regimen since the 180‐day landmark. NOAC indicates nonvitamin K antagonist oral anticoagulant.